Diclofenac for the Treatment of Patients With Metastatic Non-small Cell Lung Cancer on Single Agent Immunotherapy

NCT06731270 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Advanced Lung Non-Small Cell Carcinoma
Metastatic Lung Non-Small Cell Carcinoma
Stage III Lung Cancer AJCC v8
Stage IV Lung Cancer AJCC v8

Interventions

BIOLOGICAL: Atezolizumab
PROCEDURE: Biospecimen Collection
BIOLOGICAL: Cemiplimab
PROCEDURE: Computed Tomography
DRUG: Diclofenac Potassium
OTHER: Electronic Health Record Review
PROCEDURE: Magnetic Resonance Imaging
BIOLOGICAL: Nivolumab
BIOLOGICAL: Pembrolizumab
PROCEDURE: Positron Emission Tomography

Sponsor

Emory University

Collaborators

[object Object]